TScan Therapeutics Announces $30 Million Registered Direct OfferingOn December 26, 2024, TScan Therapeutics, Inc. (NASDAQ: TCRX) entered into a securities purchase agreement with Lynx1 Capital Management LP, an existing shareholder, and an investment
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read TScan Therapeutics’s 8K filing here. TScan Therapeutics Company Profile (Get Free Report) TScan Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients […]
More Stories
ARK 21Shares Active On-Chain Bitcoin Strategy ETF (NYSEARCA:ARKC) Announces $3.18 Dividend
ARK 21Shares Active On-Chain Bitcoin Strategy ETF (NYSEARCA:ARKC – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends...
Polar Power, Inc. (NASDAQ:POLA) Short Interest Update
Polar Power, Inc. (NASDAQ:POLA – Get Free Report) was the recipient of a large decrease in short interest during the...
Short Interest in iShares MSCI EAFE Small-Cap ETF (NASDAQ:SCZ) Decreases By 24.8%
iShares MSCI EAFE Small-Cap ETF (NASDAQ:SCZ – Get Free Report) was the recipient of a large drop in short interest...
Brandes International ETF (BATS:BINV) Announces $0.16 Dividend
Brandes International ETF (BATS:BINV – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends reports. Investors of record...
BondBloxx JP Morgan USD Emerging Markets 1-10 Year Bond ETF (BATS:XEMD) Declares Dividend Increase – $0.23 Per Share
BondBloxx JP Morgan USD Emerging Markets 1-10 Year Bond ETF (BATS:XEMD – Get Free Report) declared a dividend on Friday,...
Aptus Collared Investment Opportunity ETF (BATS:ACIO) Announces Dividend of $0.03
Aptus Collared Investment Opportunity ETF (BATS:ACIO – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends reports. Investors...